Literature DB >> 12558567

Gabapentin increases the hyperpolarization-activated cation current Ih in rat CA1 pyramidal cells.

Rainer Surges1, Thomas M Freiman, Thomas J Feuerstein.   

Abstract

PURPOSE: Gabapentin (GBP) is a commonly used drug in the treatment of partial seizures, but its mode of action is still unclear. The genesis of seizures in temporal lobe epilepsy is thought to be crucially influenced by intrinsic membrane properties. Because the Ih substantially contributes to the intrinsic membrane properties of neurons, the effects of GBP on the Ih were investigated in CA1 pyramidal cells of rat hippocampus.
METHODS: CA1 pyramidal cells in hippocampal slices were examined by using the whole-cell patch-clamp technique.
RESULTS: GBP increased the Ih amplitude in a concentration-dependent manner mainly by increasing the conductance, without significant changes in the activation properties or in the time course of Ih. The effects ranged from approximately 20% at 50 microM, approximately 25% at 75 microM, to approximately 35% at 100 microM GBP (at -110 mV). In the presence of intracellular cyclic adenosine monophosphate (cAMP), the effects of GBP on Ih were similar to those obtained in the absence of cAMP.
CONCLUSIONS: These results suggest that GBP increases the Ih through a cAMP-independent mechanism. Because the applied GBP concentrations were in a clinically relevant range, the observed effect may contribute to the anticonvulsant action of GBP in partial seizures and may represent a new concept of how this anticonvulsant drug works.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12558567     DOI: 10.1046/j.1528-1157.2003.36802.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  38 in total

1.  Hyperpolarization-activated cation current Ih of dentate gyrus granule cells is upregulated in human and rat temporal lobe epilepsy.

Authors:  Rainer Surges; Maria Kukley; Amy Brewster; Christiane Rüschenschmidt; Johannes Schramm; Tallie Z Baram; Heinz Beck; Dirk Dietrich
Journal:  Biochem Biophys Res Commun       Date:  2012-03-03       Impact factor: 3.575

2.  Antiepileptic drugs and cortical excitability: a study with repetitive transcranial stimulation.

Authors:  M Inghilleri; A Conte; V Frasca; A Curra'; F Gilio; M Manfredi; A Berardelli
Journal:  Exp Brain Res       Date:  2003-10-25       Impact factor: 1.972

Review 3.  Exploring HCN channels as novel drug targets.

Authors:  Otilia Postea; Martin Biel
Journal:  Nat Rev Drug Discov       Date:  2011-11-18       Impact factor: 84.694

4.  Is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisited.

Authors:  Rainer Surges; Kirill E Volynski; Matthew C Walker
Journal:  Ther Adv Neurol Disord       Date:  2008-07       Impact factor: 6.570

Review 5.  Regulation of recombinant and native hyperpolarization-activated cation channels.

Authors:  Samuel G A Frère; Mira Kuisle; Anita Lüthi
Journal:  Mol Neurobiol       Date:  2004-12       Impact factor: 5.590

Review 6.  HCN channelopathies: pathophysiology in genetic epilepsy and therapeutic implications.

Authors:  Christopher A Reid; A Marie Phillips; Steven Petrou
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

Review 7.  Hyperpolarization-Activated Cyclic Nucleotide-Gated (HCN) Channels in Epilepsy.

Authors:  Gary P Brennan; Tallie Z Baram; Nicholas P Poolos
Journal:  Cold Spring Harb Perspect Med       Date:  2016-03-01       Impact factor: 6.915

8.  Influence of aminophylline on the anticonvulsive action of gabapentin in the mouse maximal electroshock seizure threshold model.

Authors:  J J Luszczki; K Jankiewicz; M Jankiewicz; S J Czuczwar
Journal:  J Neural Transm (Vienna)       Date:  2007-08-24       Impact factor: 3.575

Review 9.  HCN Channel Targets for Novel Antidepressant Treatment.

Authors:  Stacy M Ku; Ming-Hu Han
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

Review 10.  Choosing the correct antiepileptic drugs: from animal studies to the clinic.

Authors:  Gregory L Holmes; Qian Zhao
Journal:  Pediatr Neurol       Date:  2008-03       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.